STOCK TITAN

CNO Financial (NYSE: CNO) officer surrenders 202 shares for taxes

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

CNO Financial Group Chief Accounting Officer Joel T. Koehneman reported a routine tax-related share transaction. On March 25, he surrendered 202 shares of common stock at $40.61 per share to the company to cover required tax withholding on vested restricted stock units. After this non-market disposition, he directly holds 5,090 shares of CNO common stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Koehneman Joel T.

(Last)(First)(Middle)
C/O CNO FINANCIAL GROUP, INC.
11299 ILLINOIS STREET, SUITE 200

(Street)
CARMEL INDIANA 46032

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
CNO Financial Group, Inc. [ CNO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Accounting Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/25/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/25/2026F202(1)D$40.615,090D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Shares were surrendered to the issuer to cover the required tax withholding on vested restricted stock units.
Remarks:
Heidi M. Krings, Attorney-in-Fact03/27/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CNO (CNO) disclose for Joel T. Koehneman?

CNO disclosed that Chief Accounting Officer Joel T. Koehneman surrendered 202 shares of common stock to the company. This covered tax withholding on vested restricted stock units and was not an open-market sale of shares.

Was the CNO (CNO) Koehneman transaction an open-market sale of stock?

No, the transaction was not an open-market sale. The 202 shares were surrendered back to CNO to satisfy required tax withholding on vested restricted stock units, a common non-discretionary payroll-related mechanism.

How many CNO (CNO) shares did Joel T. Koehneman surrender and at what price?

Joel T. Koehneman surrendered 202 shares of CNO common stock at a reference price of $40.61 per share. These shares were used solely to cover tax obligations tied to restricted stock unit vesting.

How many CNO (CNO) shares does Koehneman hold after this Form 4 transaction?

Following the tax-withholding disposition, Joel T. Koehneman directly holds 5,090 shares of CNO common stock. This figure reflects his position after the 202 shares were surrendered back to the issuer for tax purposes.

What does transaction code F mean in the CNO (CNO) Form 4 for Koehneman?

Transaction code F indicates shares were used to pay an exercise price or satisfy tax liability. In this case, 202 CNO shares were surrendered to cover required tax withholding on vested restricted stock units, rather than sold on the market.

What do the CNO (CNO) Form 4 footnotes reveal about Koehneman’s transaction?

The footnote explains the 202 surrendered shares covered required tax withholding on vested restricted stock units. It clarifies the disposition was a routine, issuer-directed tax event, not a discretionary sale by Joel T. Koehneman in the open market.
Cno Finl Group Inc

NYSE:CNO

View CNO Stock Overview

CNO Rankings

CNO Latest News

CNO Latest SEC Filings

CNO Stock Data

3.86B
91.97M
Insurance - Life
Accident & Health Insurance
Link
United States
CARMEL